🇺🇸 VTRS — Viatris Inc.

Healthcare
← Volver

Precio actual

16,88 USD

Máx. histórico

76,69

4151 días

Split 3:2 del 09/10/2003

Caída desde máximo

-77,99%

Rango 52 semanas

9,43 – 18,39

Variación hoy

-0,35%

Cierre anterior

16,94

Rango de hoy

16,67 – 17,02

Volumen hoy

5.732.791

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER ⓘ
—
Dividend yield
2,84% (puede no estar actualizado)
Precio objetivo analistas
18,50 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 3 días
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,84%
Fecha de pago Importe por participación
26/09/2001 0,0178 USD
27/06/2001 0,0178 USD
28/03/2001 0,0178 USD
27/12/2000 0,0178 USD
27/09/2000 0,0178 USD
28/06/2000 0,0178 USD
29/03/2000 0,0178 USD
29/12/1999 0,0178 USD
28/09/1999 0,0178 USD
28/06/1999 0,0178 USD
29/03/1999 0,0178 USD
29/12/1998 0,0178 USD
28/09/1998 0,0178 USD
26/06/1998 0,0178 USD
30/03/1998 0,0178 USD
Splits Registrados en el histórico de precios
Fecha Ratio
09/10/2003 3:2
28/01/2003 3:2
16/08/1995 3:2
03/08/1992 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/01/2001 9,94 10,06 9,50 9,50 -4,20% 5,59% 1.699.650
09/01/2001 9,78 10,14 9,72 9,92 +2,00% 4,26% 1.180.575
08/01/2001 9,58 9,78 9,58 9,72 +3,24% 2,03% 1.104.075
05/01/2001 9,81 9,89 9,39 9,42 -3,97% 5,10% 1.895.175
04/01/2001 10,36 10,61 9,33 9,81 -5,36% 12,33% 2.979.225
03/01/2001 10,86 11,03 10,33 10,36 -5,57% 6,39% 1.863.225
02/01/2001 11,08 11,28 10,89 10,97 -1,98% 3,51% 1.041.975
29/12/2000 11,33 11,33 10,94 11,19 -1,23% 3,43% 979.200
28/12/2000 11,22 11,50 11,14 11,33 +0,00% 3,22% 1.150.425
27/12/2000 11,25 11,42 11,03 11,33 -0,49% 3,46% 1.162.575
26/12/2000 11,50 11,72 11,19 11,39 -0,97% 4,59% 512.325
22/12/2000 11,28 11,53 11,17 11,50 +2,22% 3,20% 676.575
21/12/2000 11,14 11,47 11,00 11,25 +0,50% 4,24% 1.122.300
20/12/2000 11,42 11,42 11,14 11,19 -2,18% 2,43% 852.525
19/12/2000 11,22 11,50 11,22 11,44 +1,98% 2,48% 698.625
18/12/2000 11,31 11,31 11,11 11,22 +0,50% 1,72% 910.350
15/12/2000 11,11 11,31 11,11 11,17 -0,25% 1,75% 1.652.850
14/12/2000 11,39 11,58 11,17 11,19 -1,71% 3,66% 1.472.850
13/12/2000 11,42 11,83 11,25 11,39 +0,74% 5,11% 1.401.750
12/12/2000 11,69 11,94 11,28 11,31 -4,68% 5,70% 926.775
11/12/2000 12,06 12,22 11,81 11,86 -0,93% 3,46% 1.080.225
08/12/2000 11,75 12,00 11,44 11,97 +2,62% 4,73% 1.202.175
07/12/2000 11,64 11,89 11,50 11,67 +0,24% 3,34% 1.027.125
06/12/2000 11,72 11,81 11,47 11,64 +2,45% 2,84% 1.878.750
05/12/2000 10,97 11,39 10,97 11,36 +3,54% 3,80% 1.425.150
04/12/2000 11,28 11,44 10,67 10,97 -3,42% 6,90% 1.139.625
01/12/2000 10,64 11,42 10,64 11,36 +6,79% 7,31% 2.290.500
30/11/2000 10,19 10,83 10,17 10,64 +3,51% 6,54% 2.297.025
29/11/2000 10,22 10,58 10,17 10,28 +0,27% 4,08% 1.153.575
28/11/2000 10,33 10,36 10,11 10,25 -0,27% 2,42% 1.164.600